Pulse Therapeutics has developed the MED System™, a medical device that uses magnet-based technology to dissolve blood clots faster than current methods. This innovative solution has the potential to significantly reduce the number of lives lost to stroke, heart disease, and other conditions. Founded by leading physicists Francis “Duke” Creighton and Rogers Ritter, Pulse Therapeutics has attracted investors and media attention for its groundbreaking medical advancements. Dr. Creighton, the company's chief technical officer, brings over 20 years of expertise in the stroke and cardiovascular sectors, with 30 patents to his name. The MED System™ improves the delivery of FDA-approved clot-busting medication, enhancing patient outcomes by destroying clots earlier and more reliably, particularly in emergency departments.